Ledger.Open graph →
SEC Form D · filed August 1, 2017

Amplyx Pharmaceuticals, Inc

Offering
$66.7M
Sold
$40.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
San Diego, CA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

CRC Opportunistic Retail Fund I General Partner, LLC · Baltimore, MDDirectorFelix Shalit · Carmel, INExec · DirectorHarshjit Sethi · Frisco, TXDirectorManager of the General Partner CRC Opportunistic Retail Fund I GP Manager, LLC · Baltimore, MDDirectorMichael R. Ross · Salt Lake City, UTExec · DirectorNirmit Parikh · Frisco, TXDirectorVaibhav Agrawal · Frisco, TXDirectorMicaela Kelley · London, United KingdomExec · DirectorAndrew Skatoff · Santa Monica, CAExec · DirectorTamerlan Abdikeev · London, United KingdomDirectorIain Rawlinson · London, United KingdomDirectorJames Nieuwenhuys · London, United KingdomDirectorChristian Schaffalitzky · London, United KingdomDirectorTed L. Hill · BOSTON, MADirectorJohan K?Rdel · San Diego, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗